ScoreWhy is Wuhan Keqian Biology Co., Ltd. ?
1
Poor Management Efficiency with a low ROCE of 22.33%
- The company has been able to generate a Return on Capital Employed (avg) of 22.33% signifying low profitability per unit of total capital (equity and debt)
2
The company is Net-Debt Free
- Poor long term growth as Net Sales has grown by an annual rate of -1.18% and Operating profit at -0.71% over the last 5 years
- The company is Net-Debt Free
- The company has been able to generate a Return on Equity (avg) of 12.82% signifying low profitability per unit of shareholders funds
3
Poor long term growth as Net Sales has grown by an annual rate of -1.18% and Operating profit at -0.71% over the last 5 years
4
With a fall in Net Sales of -35.71%, the company declared Very Negative results in Jun 26
- The company has declared negative results for the last 3 consecutive quarters
- OPERATING CASH FLOW(Y) Lowest at CNY 452.61 MM
- ROCE(HY) Lowest at 7.78%
- INTEREST COVERAGE RATIO(Q) Lowest at 55,315.55
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Wuhan Keqian Biology Co., Ltd. for you?
Medium Risk, Low Return
Absolute
Risk Adjusted
Volatility
Wuhan Keqian Biology Co., Ltd.
-30.52%
-0.77
26.33%
China Shanghai Composite
3.23%
0.23
14.72%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
-1.18%
EBIT Growth (5y)
-0.71%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.31
Sales to Capital Employed (avg)
0.24
Tax Ratio
13.07%
Dividend Payout Ratio
70.91%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
14.23%
ROE (avg)
12.82%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
15
Industry P/E
Price to Book Value
1.28
EV to EBIT
10.98
EV to EBITDA
8.73
EV to Capital Employed
1.50
EV to Sales
3.91
PEG Ratio
NA
Dividend Yield
5.41%
ROCE (Latest)
13.62%
ROE (Latest)
8.37%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
No Trend
Mildly Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend2What is working for the Company
CASH AND EQV(HY)
Highest at CNY 4,453.29 MM
DEBT-EQUITY RATIO
(HY)
Lowest at -62.8 %
-39What is not working for the Company
OPERATING CASH FLOW(Y)
Lowest at CNY 452.61 MM
ROCE(HY)
Lowest at 7.78%
INTEREST COVERAGE RATIO(Q)
Lowest at 55,315.55
RAW MATERIAL COST(Y)
Grown by 29.4% (YoY
NET SALES(Q)
Lowest at CNY 146.29 MM
OPERATING PROFIT(Q)
Lowest at CNY 38.7 MM
OPERATING PROFIT MARGIN(Q)
Lowest at 26.46 %
PRE-TAX PROFIT(Q)
Lowest at CNY 22.66 MM
NET PROFIT(Q)
Lowest at CNY 21.59 MM
EPS(Q)
Lowest at CNY 0.08
Here's what is working for Wuhan Keqian Biology Co., Ltd.
Cash and Eqv
Highest at CNY 4,453.29 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is improving
Cash and Cash Equivalents
Debt-Equity Ratio
Lowest at -62.8 %
in the last five Semi-Annual periodsMOJO Watch
The company has been reducing its borrowing as compared to equity capital
Debt-Equity Ratio
Here's what is not working for Wuhan Keqian Biology Co., Ltd.
Net Sales
At CNY 146.29 MM has Fallen at -37.11%
over average net sales of the previous four periods of CNY 232.62 MMMOJO Watch
Near term sales trend is extremely negative
Net Sales (CNY MM)
Pre-Tax Profit
At CNY 22.66 MM has Fallen at -78.16%
over average net sales of the previous four periods of CNY 103.79 MMMOJO Watch
Near term Pre-Tax Profit trend is very negative
Pre-Tax Profit (CNY MM)
Net Profit
At CNY 21.59 MM has Fallen at -76.19%
over average net sales of the previous four periods of CNY 90.7 MMMOJO Watch
Near term Net Profit trend is very negative
Net Profit (CNY MM)
Operating Cash Flow
Lowest at CNY 452.61 MM and Fallen
In each year in the last three yearsMOJO Watch
The company's cash revenues from business operations are falling
Operating Cash Flows (CNY MM)
Interest Coverage Ratio
Lowest at 55,315.55
in the last five periodsMOJO Watch
The company's ability to manage interest payments is deteriorating
Operating Profit to Interest
Net Sales
Lowest at CNY 146.29 MM
in the last five periodsMOJO Watch
Near term sales trend is negative
Net Sales (CNY MM)
Operating Profit
Lowest at CNY 38.7 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is negative
Operating Profit (CNY MM)
Operating Profit Margin
Lowest at 26.46 %
in the last five periodsMOJO Watch
Company's profit margin has deteriorated
Operating Profit to Sales
Pre-Tax Profit
Lowest at CNY 22.66 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is negative
Pre-Tax Profit (CNY MM)
Net Profit
Lowest at CNY 21.59 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is negative
Net Profit (CNY MM)
EPS
Lowest at CNY 0.08
in the last five periodsMOJO Watch
Declining profitability; company has created lower earnings for shareholders
EPS (CNY)
Raw Material Cost
Grown by 29.4% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin
Raw Material Cost as a percentage of Sales
Non Operating Income
Highest at CNY 0.41 MM
in the last five periodsMOJO Watch
Increased income from non business activities may not be sustainable
Non Operating income
Footer loading
